MARTINA DI MODICA

Open University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Microbiology Microbiology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Lucia Sfondrini

Associate Professor In General Pathology and Immunology

University of Milan

ITALY

View details

Melanie R. Rutkowski

University of Virginia

UNITED STATES

View details

Tiziana Triulzi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Elda Tagliabue

Head of Molecular Targeting Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Gwenaelle Le Gall

University of East Anglia

UNITED KINGDOM

View details

loris de cecco

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Serenella Pupa

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Michele Sommariva

Assistant Professor

Università degli Studi di Torino

ITALY

View details

Romina Elizabeth Araya

Assistant Research Professor

George Washington University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

MARTINA DI MODICA

Research Interests

Explore related searches

Contact this professor

Articles (8)

The Emerging Role of the Microbiota in Breast Cancer Progression

HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer

Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness.

The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine.

Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer.

Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer

Collaborators (9)

Lucia Sfondrini

Melanie R. Rutkowski

Tiziana Triulzi

Elda Tagliabue

Gwenaelle Le Gall

loris de cecco

Serenella Pupa

Michele Sommariva

Romina Elizabeth Araya

Make your next move.